CODX vs MDLZ · rev $3.9M vs P/E 30, rev $38.54B
Co-Diagnostics, Inc. Common Stock (CODX) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
CODX currently screens at market cap $31.4M. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the CODX and MDLZ stock pages for the full models.
Not investment advice.